This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JACC Specialty Journals
JACC: CardioOncology - The Ticagrelor-Oncology (TICONC) Study: Implications of P2Y12 Inhibition for Metastasis and Cancer-Associated Thrombosis
Released: Jun 16, 2020
Commentary by Dr. Paul Burridge
JACC: CardioOncology - The Ticagrelor-Oncology (TICONC) Study: Implications of P2Y12 Inhibition for Metastasis and Cancer-Associated Thrombosis
00:00:00
